<html xmlns:v="urn:schemas-microsoft-com:vml"
      xmlns:o="urn:schemas-microsoft-com:office:office"
      xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page2_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page2_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title> </title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>4</o:Revision>
  <o:TotalTime>122</o:TotalTime>
  <o:Created>2004-04-30T12:57:00Z</o:Created>
  <o:LastSaved>2004-05-04T09:43:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>547</o:Words>
  <o:Characters>3122</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>26</o:Lines>
  <o:Paragraphs>6</o:Paragraphs>
  <o:CharactersWithSpaces>3834</o:CharactersWithSpaces>
  <o:Version>9.4402</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>150</w:Zoom>
  <w:DrawingGridHorizontalSpacing>6 pt</w:DrawingGridHorizontalSpacing>
  <w:DisplayHorizontalDrawingGridEvery>2</w:DisplayHorizontalDrawingGridEvery>
  <w:DisplayVerticalDrawingGridEvery>2</w:DisplayVerticalDrawingGridEvery>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-font-kerning:16.0pt;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 89.85pt 72.0pt 89.85pt;
	mso-header-margin:35.45pt;
	mso-footer-margin:35.45pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1038"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><a href="http://www.ebi.ac.uk/interpro/"
title="To the InterPro database"><span style='color:windowtext;text-decoration:
none;text-underline:none'><!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:113.25pt;
 height:36.75pt'>
 <v:imagedata src="./Page2_files/image001.jpg" o:title="InterPro_logo"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=151 height=49
src="./Page2_files/image001.jpg" v:shapes="_x0000_i1025"><![endif]></span></a></p>

<p class=MsoNormal align=center style='text-align:center'><b><span
style='font-size:28.0pt;mso-bidi-font-size:16.0pt;font-family:Arial;color:navy;
mso-font-kerning:16.0pt'>Serpins:<span style="mso-spacerun: yes">  </span></span></b><b><span
style='font-size:28.0pt;mso-bidi-font-size:16.0pt;font-family:Symbol;
mso-bidi-font-family:Arial;color:navy;mso-font-kerning:16.0pt'>a</span></b><b><span
style='font-size:28.0pt;mso-bidi-font-size:16.0pt;font-family:Arial;color:navy;
mso-font-kerning:16.0pt'>1-antitrypsin<o:p></o:p></span></b></p>

<p class=MsoNormal><b><span style='font-size:28.0pt;mso-bidi-font-size:16.0pt;
font-family:Arial;color:navy;mso-font-kerning:16.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></b></p>

<table border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse;
 mso-padding-alt:0cm 5.4pt 0cm 5.4pt'>
 <tr>
  <td width=551 valign=top style='width:413.6pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span style='font-size:28.0pt;mso-bidi-font-size:16.0pt;
  font-family:Arial;color:navy;mso-font-kerning:16.0pt'><!--[if gte vml 1]><v:shape
   id="_x0000_i1026" type="#_x0000_t75" style='width:348.75pt;height:211.5pt'>
   <v:imagedata src="./Page2_files/image002.gif" o:title="Neutrophil_elastase"/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=465 height=282
  src="./Page2_files/image002.gif" v:shapes="_x0000_i1026"><![endif]><o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr>
  <td width=551 valign=top style='width:413.6pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span style='mso-bidi-font-size:16.0pt;mso-font-kerning:
  16.0pt'>(A) Gram negative <i>E. coli</i> showing damaged membranes (B) after
  incubation with neutrophil elastase.<span style="mso-spacerun: yes"> 
  </span>(C) Gram positive <i>S. aureus</i> are unaffected by elastase.<o:p></o:p></span></b></p>
  <p class=MsoNormal><span style='font-size:10.0pt;mso-bidi-font-size:16.0pt;
  mso-font-kerning:16.0pt'>Reprinted from Microbes and Infection 4, A.
  Belaaouaj, <i>Neutrophil elastase-mediated killing of bacteria: lessons from
  targeted mutagenesis</i>, 1259-1264, 2002.<span style="mso-spacerun: yes"> 
  </span></span><span style='font-size:10.0pt;mso-bidi-font-size:12.0pt'><a
  href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12467768"
  title="A. Belaaouaj (2002) Microbes and Infection 4:1259-1264 Neutrophil elastase-mediated killing of bacteria: lessons from targeted mutagenesi ">PMID:
  12467768</a>.</span><span style='font-size:10.0pt;mso-bidi-font-size:16.0pt;
  mso-font-kerning:16.0pt'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><b><span style='font-size:16.0pt;font-family:Arial;
color:navy;mso-font-kerning:16.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></b></p>

<h1><span style='color:navy'>A balancing act<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>The fine
balance between a protease and its inhibitor is a major determinant in
maintaining tissue integrity.<span style="mso-spacerun: yes">  </span>This is
exemplified by the interplay between <span style='font-family:Symbol'>a</span>1-antitrypsin
and neutrophil elastase.<span style="mso-spacerun: yes">  </span>Neutrophils
play a critical role in host defence against invading pathogens.<span
style="mso-spacerun: yes">  </span>Neutrophils are produced in the bone marrow
and are fully mature when released into circulation to take up their role as
the first line of cellular defence.<span style="mso-spacerun: yes"> 
</span>Pro-inflammatory mediators and chemotactic attractants activate neutrophils
and draw them to the site of infection, where they act to engulf bacteria by
phagocytosis, assaulting them with an arsenal of anti-bacterial compounds that
use both oxidative and non-oxidative methods of attack.<span
style="mso-spacerun: yes">  </span>The powerful serine protease, neutrophil
elastase, is one of those anti-bacterial compounds that are clearly involved in
destroying bacteria.<span style="mso-spacerun: yes">  </span>Neutrophil
elastase is released into the phagolysome surrounding the microorganism, which
it proceeds to destroy.<span style="mso-spacerun: yes">  </span>Neutrophil
elastase is able to attack the outer membrane protein, OmpA, in gram-negative
bacteria (as shown above), helping to directly kill the pathogen by degrading
its membrane, as well as enabling other anti-bacterial compounds to gain access
to the pathogen.<span style="mso-spacerun: yes">  </span>In addition,
neutrophil elastase may help process other anti-bacterial compounds, converting
them from inactive pro-peptides into their active states, such as for
cathelicidin.</p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>Yet
neutrophil elastase can also cause problems for its host.<span
style="mso-spacerun: yes">  </span>It is one of the most destructive enzymes in
the body, with the capability of degrading extracellular matrix proteins
(including collagens, proteoglycan, fibronectin, platelet receptors, complement
receptor, thrombomodulin, lung surfactant and cadherins) and key plasma
proteins (including coagulation and complement factors, immunoglobulin, several
proteases and protease inhibitors).<span style="mso-spacerun: yes"> 
</span>Under physiological conditions, endogenous protease inhibitors, such as <span
style='font-family:Symbol'>a</span>1-antitrypsin, tightly regulate the activity
of neutrophil elastase.<span style="mso-spacerun: yes">  </span>However, at
inflammatory sites, neutrophil elastase is able to evade regulation, and once
unregulated it can induce the release of pro-inflammatory cytokines, such as
interleukin-6 and interleukin-8, leading to acute lung injury.<span
style="mso-spacerun: yes">  </span>It can even impair host defence against
infection by degrading phagocyte surface receptors and opsonins.<span
style="mso-spacerun: yes">  </span>Its negative role is illustrated by its
involvement in the tissue destruction and inflammation that characterise
numerous diseases, including hereditary emphysema, chronic obstructive
pulmonary disease, cystic fibrosis, adult respiratory distress syndrome,
ischemic-reperfusion injury and rheumatoid arthritis.<span style="mso-spacerun:
yes">  </span>Therefore, <span style='font-family:Symbol'>a</span>1-antitrypsin
plays a delicate balancing act, allowing enough neutrophil elastase to be
present for host defence, yet at the same time providing an anti-neutrophil
elastase screen to prevent excessive enzyme from injuring host tissue.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1 align=center style='text-align:center'><span style='font-size:18.0pt;
mso-bidi-font-size:16.0pt'>Next:<span style="mso-spacerun: yes">  </span><a
href="Page3.htm" title="Page 3">The suicide pact</a><o:p></o:p></span></h1>

<h1 align=center style='text-align:center'><span style='font-size:18.0pt;
mso-bidi-font-size:16.0pt'>Previous:<span style="mso-spacerun: yes">  </span></span><span
style='font-size:18.0pt;mso-bidi-font-size:16.0pt;font-family:Symbol'><a
href="Page1.htm" title="Page 1">a<span style='font-family:Arial'>1-Antitrypsin,
the archetypical serpin</span></a></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='color:navy'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

</div>

</body>

</html>
